Key takeaways
- Nigeria confirmed Bundibugyo Ebola in Abuja on 20 October 2026, about 13 days after the patient's symptoms began.
- Clinicians treated the woman for malaria at several private facilities, and authorities were alerted only on 19 October.
- Bundibugyo has no approved vaccine or licensed treatment, so containment depends on tracing, and epidemiologists say 44 contacts is too few.
- Uganda and Nigeria disagree over where she was infected, while Africa CDC warns of risk across the continent.
Nigeria's Health Ministry said on Tuesday, 20 October 2026, that a case of Bundibugyo Ebola virus disease had been confirmed in Abuja, according to AP. The patient, a 42-year-old woman, had been ill for about 13 days. She was managed for malaria-like symptoms at a private hospital from 11 October, Reuters reported. The Nigeria Centre for Disease Control and Prevention (NCDC) said three levels of testing were carried out, all of them molecular, and that the strain was Bundibugyo, while the World Health Organization (WHO) said a laboratory test confirmed the virus on 20 October.
Africa CDC (the African Union's public health agency) and diplomatic reporting identify her as a Ugandan national and the wife of a Swiss diplomat based in Abuja. She flew from Kampala, Uganda, and arrived on 3 October, after a two-week stay and a two-hour stopover in Addis Ababa, Ethiopia. One source gives 5 October as the arrival date. She developed severe complications, including multi-organ failure, and then stabilised in isolation with intensive supportive care. Her infection has not been traced to an outbreak declared in eastern Democratic Republic of the Congo (DRC) on 15 May 2026, which has since passed 9,500 cases (Crisis.Zone coverage of the DRC epidemic).
From first fever to first test
Her symptoms began on 6 or 7 October with fever, headache and malaise. Malaria is endemic in Nigeria and its early signs overlap with Ebola: fever, body aches, vomiting and diarrhoea. She sought outpatient care at several private facilities, where she was treated for malaria.
On 11 October she was admitted to a private hospital in the Federal Capital Territory. Public health authorities were alerted only on 19 October, eight days after admission. Molecular blood tests were ordered that day, and results were confirmed the next.
The delay matters because of a global benchmark known as "7-1-7". It sets a target of detecting an outbreak within seven days, notifying authorities within one day and completing early response within seven days. In this case the detection stage alone took 12 to 13 days.
Observers are reading: why the contact count, not the case count, will decide whether Abuja repeats 2014, and what exposure at private clinics means.
Become an Observer, it's free. Get full access to all Crisis.Zone analysis, briefings and breaking coverage.
A dispute over where she was infected
Where she caught the virus is contested. Ugandan authorities say she is a Nigerian who contracted Ebola on business in eastern DRC and only transited Uganda. They note that WHO declared Uganda Ebola-free on 27 August. Pate said there is no confirmed evidence she visited the DRC and presumes the infection occurred in Uganda.
WHO Representative Pavel Ursu said the information supplied to WHO did not include travel to any country other than Uganda, while Africa CDC Director-General Jean Kaseya said she did not go to the DRC, contrary to what Ugandan authorities had suggested earlier. They warned that infection in Uganda would point to undetected community transmission. Infection acquired in the DRC would mean she crossed the border unnoticed.
Kenya has confirmed nine cases from an index case imported from the DRC via Uganda (Kenya's surveillance response). Kaseya said Africa CDC must redraw its continental risk map to include West, North and Southern Africa: "No one is safe today." The next test is whether Abuja's contact tracing reaches beyond the first 44 people.
Become an Observer (it's free) to unlock direct links to all sources used in this article.
We believe you deserve to verify everything we write. That's why we meticulously document every source.
